Your browser doesn't support javascript.
loading
Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells.
Chakravarty, Geetika; Mathur, Aditi; Mallade, Pallavi; Gerlach, Samantha; Willis, Joniece; Datta, Amrita; Srivastav, Sudesh; Abdel-Mageed, Asim B; Mondal, Debasis.
Afiliación
  • Chakravarty G; Department of Pharmacology, Tulane University Medical Center, USA.
  • Mathur A; Department of Pharmacology, Tulane University Medical Center, USA.
  • Mallade P; Department of Pharmacology, Tulane University Medical Center, USA.
  • Gerlach S; Department of Pharmacology, Tulane University Medical Center, USA.
  • Willis J; Department of Pharmacology, Tulane University Medical Center, USA.
  • Datta A; Department of Urology, Tulane University Medical Center, USA.
  • Srivastav S; Department of Biostatistics, Tulane University School of Public Health and Tropical Medicine, USA.
  • Abdel-Mageed AB; Department of Urology, Tulane University Medical Center, USA.
  • Mondal D; Department of Pharmacology, Tulane University Medical Center, USA. Electronic address: dmondal@tulane.edu.
Biochimie ; 124: 53-64, 2016 May.
Article en En | MEDLINE | ID: mdl-26844637

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Doxorrubicina / Resistencia a Múltiples Medicamentos / Resistencia a Antineoplásicos / Nelfinavir Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Biochimie Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Doxorrubicina / Resistencia a Múltiples Medicamentos / Resistencia a Antineoplásicos / Nelfinavir Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Biochimie Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos